Experiences with Fosinopril

Experiences with Fosinopril

This page shows detailed information about a drug such as statistics, patient reviews and related articles.

C09AA09
ATC Code
Manufacturer: Not specified.
Generic Drug: Yes
C09AA09
ATC Code
Manufacturer: Not specified.
Generic Drug: Yes
Positive effects: No positive effects specified.
Negative effects: No negative effects specified.

Level of
Satisfaction

Level of<br>Satisfaction 0%

What patients say...

Effectiveness 25%
Quantity of side effects 62%
Severity of side effects 62%
Ease of use 100%

Our patients

Our patients, demographics

Read an article related with this drug...

Read an article related with this drug...

No articles...

At the moment there are no articles about this drug.

Read our patient's reviews about Fosinopril

Read our patient's reviews about Fosinopril

Fosinopril

6/22/2016 | | 60
Fosinopril (20mg) for thrombosis

was intended for better circulation and clot reduction. I think there may have been side-effects when I started but I can't remember any more. Until 2012 and from 1 April 2016. Following dermatological investigation it would seem that this medicine was the primary cause for a severe allergic attack which caused me to be hospitalised, in combination with the drugs I was injected with in the pain...
> read full review......

No positive effects specified.
No negative effects specified.

Fosinopril

4/21/2016 | | 56
Fosinopril (10mg) for high blood pressure

Personally, I am always tired, but what this medicine is doing to me is awful. Muscle pains all over my entire body (which is not mentioned in the list of side effects). Groggy, derealisation, no idea if I'm even alive any more. What a piece of junk. Am I the only one here with these side effects?
> read full review......

No positive effects specified.
No negative effects specified.

Most reviewed drugs

Most reviewed drugs


Copyright © 2008-2018 Insight Pharma Services BV.
All rights reserved.
Icons made by Prosymbols from www.flaticon.com and licensed as CC 3.0 BY.